Hypoglycemic, antilipidemic and antioxidant effects of valproic acid in alloxan-induced diabetic rats

European Journal of Pharmacology

Volumn 762, Issue 1, 2015, Pages 174-183

  Akindele, Abidemi J ^a   Otuguor, Edafe ^a   Singh, Dhirendra ^b   Ota, Duncan ^a   Benebo, Adokiye S ^c  

^a UNIVERSITY OF LAGOS   (Nigeria)

^b Department of Pharmacology Shakambhari Institute of Higher Education and Technology   (India)

^c LAGOS STATE UNIVERSITY   (Nigeria)

Author keywords

Alloxan; Antilipidemic; Antioxidant; Diabetes; Hypoglycemic; Valproic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CHOLESTEROL; CREATININE; GLUCOSE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UREA; VALPROIC ACID; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; CALCIUM; GLUCOSE BLOOD LEVEL; HYDROGEN PEROXIDE; LIPID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTILIPIDEMIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG ACTIVITY; DRUG EFFECT; ENZYME BLOOD LEVEL; GLUCOSE BLOOD LEVEL; KIDNEY PARENCHYMA; LIPOPROTEIN BLOOD LEVEL; LIVER PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; ANIMAL; BLOOD; BODY WEIGHT; CYTOSOL; DIABETES MELLITUS, EXPERIMENTAL; DRINKING; DRUG EFFECTS; KIDNEY; LIVER; METABOLISM; ORGAN SIZE; PANCREAS ISLET BETA CELL; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; CALCIUM; CYTOSOL; DIABETES MELLITUS, EXPERIMENTAL; DRINKING; HYDROGEN PEROXIDE; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN-SECRETING CELLS; KIDNEY; LIPIDS; LIVER; MALE; MALONDIALDEHYDE; ORGAN SIZE; RATS; RATS, WISTAR; VALPROIC ACID;

EID: 84937430578     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.05.044     Document Type: Article

References (29)

1. R.R. Abraham, A. Dornhorst, V. Wynn, A.R. Altaher, E.A. Campbell, U. Beckford, S.M. Watts, S.A. Nicholson, B. Gillham, A. Thody, and et al. Corticotrophin, cortisol, prolactin and growth hormone responses to insulin-induced hypoglycaemia in normal subjects given sodium valproate Clin. Endocrinol. 22 5 1985 639 644
2. M. Aragno, E. Brignardello, E. Tamagno, V. Gatto, O. Danni, and G. Boccuzzi Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats J. Endocrinol. 155 2 1997 233 240
3. S. Chateauvieux, F. Morceau, M. Dicato, and M. Diederich Molecular and therapeutic potential and toxicity of valproic acid J. Biomed. Biotechnol. 2010 2010 479364 10.1155/2010/479364
4. D.P. Christensen, M. Dahllöf, M. Lundh, D.N. Rasmussen, M.D. Nielsen, N. Billestrup, L.G. Grunnet, and T. Mandrup-Poulsen Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus Mol. Med. 17 5-6 2011 378 390
5. Committee for the Update of the Guide for the Care and Use of Laboratory Animals Guide for the Care and Use of Laboratory Animals 8th ed. 2011 National Academies Press Washington, DC
6. O.K. Dada, A.J. Akindele, O.A. Morakinyo, M.O. Sofidiya, and D. Ota Hypoglycemic and antioxidant activities of the hydroethanolic leaf extract of Byrsocarpus coccineus Schumach. & Thonn. (Connaraceae) Chin. J. Nat. Med. 11 6 2013 628 637
7. H. Dinesen, L. Gram, T. Andersen, and M. Dam Weight gain during treatment with valproate Acta Neurol. Scand. 70 1984 65 69
8. F. Ebbesen, A. Joergensen, E. Hoseth, P.H. Kaad, M. Moeller, V. Holsteen, and M. Rix Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate Arch. Dis. Child Fetal Neonatal Ed. 83 2000 124 129
9. H. Gough, T. Goggin, M. Crowley, and N. Callaghan Serum bilirubin levels with antiepileptic drugs Epilepsia 30 5 1989 597 602
10. P.V. Habbu, R.A. Shasty, K.M. Mahadaven, H. Joshi, and S.K. Das Hepatoprotective and antioxidant effects of Agyreia speciosa in rats Afr. J. Tradit. Complement. Altern. Med. 5 2 2008 158 164
11. G. Lehrman, I.B. Hogue, S. Palmer, C. Jennings, C.A. Spina, A. Wiegand, A.L. Landay, R.W. Coombs, D.D. Richman, J.W. Mellors, J.M. Coffin, R.J. Bosch, and D.M. Margolis Depletion of latent HIV-1 infection in vivo: a proof-of-concept study Lancet 366 9485 2005 549 555
12. G. Luef, I. Abraham, F. Hoppichler, E. Trinka, I. Unterberger, G. Bauer, and M. Lechleitner Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy Metabolism 51 2002 1274 1278
13. G.J. Luef, M. Lechleitner, G. Bauer, E. Trinka, and P. Hengster Valproic acid modulates islet cell insulin secretion: a possible mechanism of weight gain in epilepsy patients Epilepsy Res. 55 2003 53 58
14. A.M. Mahmoud Hematological alterations in diabetic rats-role of adipocytokines and effect of citrus flavonoids EXCLI J. 12 2013 647 657
15. B. Murali, U.M. Upadhyaya, and R.K. Goyal Effect of chronic treatment with Enicostemma littorale in non-insulin-dependent diabetic (NIDDM) rats J. Ethnopharmacol. 81 2002 199 204
16. M. Murray, and J. Pizzorno Encyclopedia of Natural Medicine 2nd edition 1997 Prima Health Publishing Rockling, USA 401
17. M. Neelesh, J. Sanjay, and M. Sapna Antidiabetic potential of medicinal plants Acta Pol. Pharm. 67 2010 113 118
18. I.B. Okwa, A.J. Akindele, E.O. Agbaje, O.T. Oshinuga, C.C. Anunobi, and O.O. Adeyemi Effect of subclinical, clinical and supraclinical doses of calcium channel blockers on models of drug-induced hepatotoxicity in rats EXCLI J. 12 2013 231 250
19. H.S. Seltzer Drug-induced hypoglycemia. A review of 1418 cases Endocrinol. Metab. Clin. N. Am. 18 1989 163 183
20. E. Sezik, M. Aslan, E. Yesilada, and S. Ito Hypoglycaemic activity of Gentiana olivieri and isolation of the active constituent through bioassay-directed fractionation techniques Life Sci. 76 11 2005 1223 1238
21. A.N. Shafik Effects of topiramate on diabetes mellitus induced by streptozotocin in rats Eur. J. Pharmacol. 684 2012 161 167
22. S.J. Shuttleworth, S.G. Bailey, and P.A. Townsend Histone Deacetylase inhibitors: new promise in the treatment of immune and inflammatory diseases Curr. Drug Targets 11 11 2010 1430 1438
23. M.F. Silva, C.C. Aires, P.B. Luis, J.P. Ruiter, L. IJIst, M. Duran, R.J. Wanders, and I. Tavares de Almeida Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review J. Inherit. Metab. Dis. 31 2008 205 216
24. Y.Y. Soon, and B.K. Tan Evaluation of the hypoglycemic and antioxidant activities of Morinda officinalis in streptozotocin-induced diabetic rats Singap. Med. J. 43 2 2002 077 085
25. T. Szkudelski The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas Physiol. Res. 50 6 2001 537 546
26. M. Umamaheswari, and T.K. Chatterjee Effect of the fractions of Coccinia grandis on ethanol-induced cerebral oxidative stress in rats Pharmacogn. Res. 1 1 2009 25 34
27. M.P. van den Broek, M.A. Sikma, T.F. Ververs, and J. Meulenbelt Severe valproic acid intoxication: case study on the unbound fraction and the applicability of extracorporeal elimination Eur. J. Emerg. Med. 16 6 2009 330 332
28. E.C. Wirrell Valproic acid-associated weight gain in older children and teens with epilepsy Pediatr. Neurol. 28 2003 126 129
29. W. Zhou, H. Chai, P.H. Lin, A.B. Lumsden, Q. Yao, and C. Chen Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular disease Cardiovasc. Drug Rev. 22 4 2006 309 319